Glaucoma: Diagnosis and Management.
Michels TC, Ivan O.
Am Fam Physician. 2023 Mar;107(3):253-262.
Incidence of Glaucoma in Type 2 Diabetes Patients Treated With GLP-1 Receptor Agonists: A Systematic Review and Meta-Analysis.
Asif M, Asif A, Rahman UA, Farooqi HA, Fatima O, Ali W, Jafar U, Jaber MH.
Endocrinol Diabetes Metab. 2025 Jul;8(4):e70059. doi: 10.1002/edm2.70059.
GLP-1 Receptor Agonists and Sight-Threatening Ophthalmic Complications in Patients With Type 2 Diabetes.
Ramsey DJ, Makwana B, Dani SS, Patel M, Panchal K, Shah J, Khadke S, Kumar A, Patel T, Kosiborod MN, Fonarow GC, Ramsey KM, Nohria A, Butler J, Ganatra S.
JAMA Netw Open. 2025 Aug 1;8(8):e2526321. doi: 10.1001/jamanetworkopen.2025.26321.
Association between Glucagon-like Peptide-1 Receptor Agonists and the Risk of Glaucoma in Individuals with Type 2 Diabetes.
Niazi S, Gnesin F, Thein AS, Andreasen JR, Horwitz A, Mouhammad ZA, Jawad BN, Niazi Z, Pourhadi N, Zareini B, Meaidi A, Torp-Pedersen C, Kolko M.
Ophthalmology. 2024 Sep;131(9):1056-1063. doi: 10.1016/j.ophtha.2024.03.004. Epub 2024 Mar 13.
Association of Primary Open-Angle Glaucoma with Diabetic Retinopathy among Patients with Type 1 and Type 2 Diabetes: A Large Global Database Study.
Chauhan MZ, Elhusseiny AM, Kishor KS, Sanvicente CT, Ali AA, Sallam AB, Bhattacharya SK, Uwaydat SH.
Ophthalmology. 2024 Jul;131(7):827-835. doi: 10.1016/j.ophtha.2024.01.016. Epub 2024 Jan 10.
Aloe-emodin: A review of its pharmacology, toxicity, and pharmacokinetics.
Dong X, Zeng Y, Liu Y, You L, Yin X, Fu J, Ni J.
Phytother Res. 2020 Feb;34(2):270-281. doi: 10.1002/ptr.6532. Epub 2019 Nov 3.
An update on ocular effects of antidiabetic medications.
Sadeghi E, Rahmanipour E, Valsecchi N, Kapoor S, Cicinelli MV, Chhablani J.
Surv Ophthalmol. 2025 Jul-Aug;70(4):704-712. doi: 10.1016/j.survophthal.2025.01.010. Epub 2025 Jan 22.
Neurodegeneration in Patients with Type 2 Diabetes Mellitus without Diabetic Retinopathy.
Garcia-Martin E, Cipres M, Melchor I, Gil-Arribas L, Vilades E, Polo V, Rodrigo MJ, Satue M.
J Ophthalmol. 2019 Aug 7;2019:1825819. doi: 10.1155/2019/1825819. eCollection 2019.
Type 2 Diabetes, Fasting Glucose, Hemoglobin A1c Levels and Risk of Primary Open-Angle Glaucoma: A Mendelian Randomization Study.
Hu Z, Zhou F, Kaminga AC, Xu H.
Invest Ophthalmol Vis Sci. 2022 May 2;63(5):37. doi: 10.1167/iovs.63.5.37.
Time to Progression to Proliferative Diabetic Retinopathy in Patients With Type 2 Diabetes.
Kim IM, Radgoudarzi N, Chen EM, Liu J, Moussa K, Shantha JG, Tsui E, Gore C, Baxter SL, Porco TC, Arnold BF, Sun CQ.
JAMA Netw Open. 2025 Jul 1;8(7):e2521150. doi: 10.1001/jamanetworkopen.2025.21150.
